Somewhere in Amsterdam there is a developer who has invoiced the same foreign company every month for three years. Same rate, same hours, same Slack channel, same standup at 09:30. Everyone involved has always called it a contractor relationship. As of…
Quantum computing has alternated between breakthrough darling and overhyped promise in technology circles. Its powerful new capabilities come with a threat to break current cryptography, but for business leaders navigating the noise, the signal should be clear: post-quantum cryptography (PQC) is a manageable evolution, not a crisis. The mathematics behind today’s encrypted digital transactions may…
Business and technology leaders need no convincing that the time of agentic AI is here. Organizations are rapidly adopting agents, and few executives doubt the technology’s potential to transform work. But many organizations find that realizing the desired return on investment (ROI) from AI hinges on having the right foundation, with inadequate infrastructure and data…
The resignation landed on a Tuesday, and the manager never saw it coming. A senior engineer with three years at the company had earned strong reviews and showed no obvious signs of frustration. Then came the resignation. A competing offer had already b…
Imagine a healthcare system made up of multiple AI agents: one that manages symptom assessment, another scheduling, a third insurance, and a fourth pharmacy. Each is an expert in its domain. But they all have their own distinct knowledge and objectives. Today they can exchange data, but they are not yet able to actually coordinate…
Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market takes an average of 10-15 years and costs…
For the enterprise, the promise of agentic AI is much more than just a better chatbot. It is software agents that execute business tasks end-to-end across people, business workflows, data, and systems. The platform best-suited to run agents is built with proper CPU capacity, resilient data access, policy-aware tool use, observability, memory management, and the…
Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered proteins rather than synthetic chemistry (which are often used to…
The conversation about AI often centers on algorithms, computing power, or huge investments in new semiconductor fabrication plants and hyperscale data centers. But beneath each of these advances is another layer of innovation that makes them possible: advanced materials. Every new generation of AI technology demands more processing power, more memory, greater energy efficiency, and…
With the rapid progress of AI capabilities and the move to agentic systems, organizations are expanding their use cases as the technology continues to grow. That constant evolution also introduces risk, leaving IT leaders to wonder which investments will prove valuable even six months into the future. Returning to the foundational elements of AI architecture—the…